Arginase Deficiency

  • Living reference work entry
  • First Online:
Genetic Syndromes

Abstract

Arginase deficiency is caused by biallelic pathogenic variants of ARG1 gene. Arginase 1 deficiency results in hepatic accumulation of intracellular arginine and release of excess arginine into the blood, which subsequently accumulates in the brain and cerebrospinal fluid. The neurological complications of the disease appear to be a consequence of the neurotoxic effects of arginine and/or guanidino compounds. Unlike the typical presentation of other urea cycle disorders, most individuals with arginase deficiency show minimal or no symptoms at birth and less severe hyperammonemia. Affected patients appear to have minimal symptoms if treated from birth or early childhood, while untreated individuals may exhibit progressive motor symptoms, intellectual disability, and loss of developmental milestones.

OMIM: #207800

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neluwa-Liyanage R. Indika .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Indika, NL.R., Senarathne, U.D., Schulze, A. (2023). Arginase Deficiency. In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_1328-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66816-1_1328-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66816-1

  • Online ISBN: 978-3-319-66816-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Navigation